Company Description
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
The company offers integrated platform for health plan administration and value-based business infrastructure.
It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.
In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence.
Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Country | United States |
Founded | 2011 |
IPO Date | Jun 5, 2015 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 4,500 |
CEO | Seth Blackley |
Contact Details
Address: 1812 N. Moore Street, Suite 1705 Arlington, Virginia 22209 United States | |
Phone | 571 389 6000 |
Website | evolent.com |
Stock Details
Ticker Symbol | EVH |
Exchange | NYSE |
Stock Type | Common Stock |
Share Class | Class A Shares |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001628908 |
CUSIP Number | 30050B101 |
ISIN Number | US30050B1017 |
Employer ID | 32-0454912 |
SIC Code | 8741 |
Key Executives
Name | Position |
---|---|
Seth Barrie Blackley | Co-Founder, Chief Executive Officer and Director |
Dan McCarthy | President |
John Paul Johnson | Chief Financial Officer |
Emily Rafferty | Chief Operating Officer |
Jonathan David Weinberg J.D. | Chief Legal Officer, General Counsel and Secretary |
Aammaad Shams | Chief Accounting Officer |
Robert Cruz | Chief Technology Officer |
Jessica White | Chief Information Officer |
Seth R. Frank | Vice President of Investor Relations |
Katie DiPerna Cook | Chief People Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 15, 2025 | SCHEDULE 13G | Filing |
May 14, 2025 | SCHEDULE 13G | Filing |
May 9, 2025 | 10-Q | Quarterly Report |
May 8, 2025 | 8-K | Current Report |
Apr 25, 2025 | ARS | Filing |
Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
Apr 22, 2025 | 8-K | Current Report |
Feb 25, 2025 | 144 | Filing |
Feb 21, 2025 | 10-K | Annual Report |